Norges Bank bought a new position in shares of Option Care Health, Inc. (NASDAQ:OPCH - Free Report) in the 4th quarter, according to its most recent Form 13F filing with the SEC. The fund bought 2,595,640 shares of the company's stock, valued at approximately $60,219,000. Norges Bank owned approximately 1.53% of Option Care Health at the end of the most recent reporting period.
Several other large investors also recently bought and sold shares of the stock. Cornerstone Investment Partners LLC raised its stake in Option Care Health by 3.6% in the fourth quarter. Cornerstone Investment Partners LLC now owns 9,544 shares of the company's stock valued at $221,000 after buying an additional 333 shares in the last quarter. UMB Bank n.a. increased its holdings in shares of Option Care Health by 41.7% in the 4th quarter. UMB Bank n.a. now owns 1,176 shares of the company's stock valued at $27,000 after acquiring an additional 346 shares during the last quarter. Assetmark Inc. raised its position in shares of Option Care Health by 2.0% during the 4th quarter. Assetmark Inc. now owns 24,976 shares of the company's stock worth $579,000 after acquiring an additional 487 shares in the last quarter. Pacer Advisors Inc. lifted its stake in Option Care Health by 2.2% during the fourth quarter. Pacer Advisors Inc. now owns 25,483 shares of the company's stock worth $591,000 after purchasing an additional 537 shares during the last quarter. Finally, Sheets Smith Wealth Management boosted its holdings in Option Care Health by 2.4% in the fourth quarter. Sheets Smith Wealth Management now owns 23,856 shares of the company's stock valued at $553,000 after purchasing an additional 550 shares in the last quarter. Hedge funds and other institutional investors own 98.05% of the company's stock.
Option Care Health Stock Performance
Shares of NASDAQ:OPCH traded down $0.08 during midday trading on Tuesday, hitting $32.79. The stock had a trading volume of 1,583,474 shares, compared to its average volume of 1,740,529. Option Care Health, Inc. has a 1 year low of $21.39 and a 1 year high of $35.53. The company has a current ratio of 1.73, a quick ratio of 1.32 and a debt-to-equity ratio of 0.77. The stock has a 50 day moving average price of $33.07 and a two-hundred day moving average price of $28.53. The company has a market capitalization of $5.39 billion, a PE ratio of 27.55, a P/E/G ratio of 2.30 and a beta of 1.07.
Insider Activity at Option Care Health
In other Option Care Health news, insider Michael Bavaro sold 30,996 shares of the stock in a transaction on Friday, February 28th. The stock was sold at an average price of $33.26, for a total value of $1,030,926.96. Following the completion of the transaction, the insider now owns 44,974 shares in the company, valued at approximately $1,495,835.24. This represents a 40.80 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link. 0.64% of the stock is owned by insiders.
Analyst Ratings Changes
A number of analysts have weighed in on the stock. Barrington Research raised their price objective on shares of Option Care Health from $33.00 to $38.00 and gave the stock an "outperform" rating in a report on Thursday, February 27th. Jefferies Financial Group raised shares of Option Care Health from a "hold" rating to a "buy" rating and boosted their price target for the company from $26.00 to $35.00 in a research report on Thursday, January 23rd. Bank of America upgraded Option Care Health from a "neutral" rating to a "buy" rating and lifted their target price for the stock from $26.00 to $33.00 in a research report on Monday, January 13th. JMP Securities reaffirmed a "market outperform" rating and set a $30.00 price target (down previously from $31.00) on shares of Option Care Health in a research report on Friday, January 10th. Finally, JPMorgan Chase & Co. raised their target price on shares of Option Care Health from $40.00 to $41.00 and gave the stock an "overweight" rating in a research report on Thursday, March 6th. Two investment analysts have rated the stock with a hold rating and six have given a buy rating to the company. According to data from MarketBeat.com, Option Care Health currently has an average rating of "Moderate Buy" and a consensus target price of $33.00.
Read Our Latest Research Report on OPCH
Option Care Health Profile
(
Free Report)
Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn's disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.
Recommended Stories
Before you consider Option Care Health, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Option Care Health wasn't on the list.
While Option Care Health currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
If a company's CEO, COO, and CFO were all selling shares of their stock, would you want to know? MarketBeat just compiled its list of the twelve stocks that corporate insiders are abandoning. Complete the form below to see which companies made the list.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
